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Abstract
Background: The Hippo signaling pathway is reported to be involved in angiogenesis, but the roles of the Hippo
pathway in diabetic retinopathy have not been addressed. Fufang Xueshuantong Capsule has been used to treat
diabetic retinopathy in China; however, the effect of Fufang Xueshuantong Capsule on the Hippo pathway has not
been investigated.
Methods: In this study, diabetes was induced in Sprague-Dawley rats with intraperitoneal injection of streptozotocin.
Twenty weeks later, Fufang Xueshuantong Capsule was administered for 12 weeks. When the administration ended,
the eyes were isolated for western blot and immunohistochemistry analyses. The levels of P- mammalian sterile 20-like
(MST), large tumor suppressor homolog (Lats), P- yes-associated protein (YAP), transcriptional co-activator with PDZ
binding motif (TAZ) and TEA domain family members (TEAD) were measured.
Results: Diabetic rats had a decreased P-MST level in the inner plexiform layer and reduced expression of P-YAP in the
photoreceptor layers of their eyes. In addition, diabetic rats displayed remarkable increases in Lats, TAZ and TEAD in
their retinas. Furthermore, Fufang Xueshuantong Capsule restored the changes in the Hippo pathway.
Conclusions: The Hippo signaling pathway is important for the progression of diabetic retinopathy and will hopefully
be a targeted therapeutic approach for the prevention of diabetic retinopathy.
Keywords: Diabetic retinopathy, Chinese medicine, Hippo
Background
Diabetic retinopathy (DR) is one of the most prominent
complications of diabetes. DR remains a leading cause of
blindness and is characterized by vascular abnormalities,
including increased permeability and the growth of new
blood vessels [1]. At present, controlled systemic deregula-
tion, laser photocoagulation, vitreoretinal surgery and in-
travitreal anti-vascular endothelial growth factor (VEGF)
drugs remain the most common approaches to slow the
development and progression of DR [2]; however, some
existing limitations and the fact that some patients re-
spond poorly to these treatments has led to the need for
novel therapies for DR [3]. In addition, these findings sug-
gest suggests that some other mediators or pathways may
participate and play an important role in DR. Therefore, it
is important to elucidate the exact mechanisms of DR and
then investigate targeted ways to arrest the progression of
this disease.
The Hippo pathway is newly discovered and plays import-
ant roles in organ size control [4]. The pathway consists of
a large number of kinases and proteins, and the core mem-
bers are mammalian sterile 20-like(MST), large tumor sup-
pressor homolog(Lats), MOB kinase activator1(Mob1), and
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salvador1(hsav1) [5]. The kinase cascade phosphorylates
yes-associated protein(YAP), transcriptional co-activator
with PDZ binding motif(TAZ) and TEA domain family
members(TEAD), which control cell proliferation [6, 7].
It has been reported that Lats [8] and YAP [9] partici-
pate in the proliferation of endothelioma cells and vas-
cular smooth muscle cell, respectively [10, 11]. In
addition, Lats [8] and YAP [10] regulate angiogenesis in
zebrafish. It is striking that YAP, which is the effector of
the Hippo pathway, is expressed in retinal vessels and
involved in endothelial sprouting [12] and angiogenesis
[13]. It is well known that angiogenesis, which accom-
panies the proliferation of endothelial cells, is a symp-
tom of DR. Thus, these previous studies suggest that the
Hippo pathway plays roles in DR.
To identify the specific roles of the Hippo signaling
pathway in the progression of DR, the influence of
Fufang Xuesuhangtong (XST) Capsule, a patented
Chinese drug that is reported to impede DR, on the
Hippo pathway was investigated. XST, which is com-
posed of Panax notoginseng, Salvia miltiorrhiza, As-
tragalus membranaceus and Scrophularia ningpoensis,
has been noted for its medicinal effect against DR for
almost 20 years. Many clinical studies have indicated
that XST could prevent fundus hemorrhage and exud-
ation and stable vision in DR patients [14]. After-
wards, XST has been found to ameliorate whole
blood viscosity, plasma viscosity, and erythrocyte ag-
gregation indexes in STZ-induced rats [15]. Moreover,
XST suppresses the acellular capillaries and increase
the pericyte numbers, which are the characteristics of
DR in rats [15]. In addition XST decreases the base-
ment membrane thickness of the capillary and im-
proved the pathological changes of the ganglion cells
in the retina of diabetic rats [16]. Meanwhile XST at-
tenuates the aldose reductase activity and the content
of malondialdehyde (MDA), diminishes the expression
of VEGF, intercellular cell adhesion molecule-1
(ICAM-1) and inducible nitric oxide synthase (iNOS),
and augments the level of superoxide dismutase
(SOD), pigment epithelium-derived factor (PEDF) and
occludin [15, 16]. Furthermore, recent studies have
shown that the characteristic constituents of XST
have the same pharmacological effect on DR [17].
We hypothesize that the Hippo signaling pathway par-
ticipates in the process of DR and that XST has an impact
on this pathway. Thus, the expression or distribution of
proteins in the Hippo pathway was investigated in the ret-
inas of diabetic rats. In addition, the changes in the core
members in the Hippo pathway were examined in rat
retinas after XST administration. This study will enhance
the understanding of the mechanisms promoting the de-
velopment of DR and provide valuable indications for a
novel therapeutic target for DR.
Methods
Ethics statement
All procedures involving animals and their care were
carried out according to the governmental guidelines
on animal experimentation and the National Institutes
of Health’s “Principles of Laboratory Animal Care”. All
experimental protocols were approved by the Institu-
tional Animal Ethics Committee of Beijing University
of Traditional Chinese Medicine, Beijing, China (Permit
Number: 26–1514).
Antibodies
Anti-VEGF antibody, Abcam (Cambridge, UK), ab1316,
mouse monoclonal, western blot (WB) dilution: 1:250;
anti-extracellular signal-regulated kinas (Erk1) (pT202/
pY204) + Erk2 (pT185/pY187) antibody, Abcam, ab4819,
rabbit polyclonal, western blot (WB) dilution: 1:1000; anti-
Erk1/2 antibody, Abcam, ab17942, rabbit polyclonal, west-
ern blot (WB) dilution: 1:1000; anti-Lats antibody, Santa
Cruz (Dallas, Texas, U.S.A.), sc-9388, goat polyclonal,
western blot (WB) dilution: 1:200; anti-TAZ antibody,
Santa Cruz, sc-48,805, rabbit polyclonal, western blot
(WB) dilution: 1:500; anti-TEAD antibody, Santa Cruz, sc-
134,070, rabbit polyclonal, western blot (WB) dilution:
1:1000; anti-β-actin antibody, Abcam, ab8226, mouse
monoclonal, western blot (WB) dilution: 1:5000; P-MST,
CST (Boston, Massachusetts, USA), #3681, rabbit poly-
clonal, immunohistochemistry dilution: 1:250; P-YAP,
CST, # 4911, rabbit polyclonal, immunohistochemistry di-
lution: 1:250.
Drug
XST (national medicine permission number Z20030017,
lot number 130630) was purchased from Zhongsheng
Pharmaceutical Co., Ltd. (Guangdong, China). There
was 0.5 g drug per grain.
Animals
Thirty six Male healthy, Sprague-Dawley rats (8 weeks
of age, 250–300 g) were supplied by Vital River Labora-
tory Animal Technology Co. Ltd. (Beijing, China, Cer-
tificate no SCXK (Beijing) 2007–0001). The animals
were kept at a room temperature of 22–24 °C, 40% hu-
midity, and a 12-h daylight cycle. The rats were housed
in 465 × 300 × 200 mm cages (Longdonghai Ltd., China,
Type II) and provided with water and commercial rat
feed ad libitum. Three rats were raised in one cage. The
beddings were changed every day, and the cages were
changed every week. When the experiments ended, the
animals were sacrificed using intraperitoneal injections
of pentobarbital (50 mg/kg). The status of rats was ex-
amined every day and the blood glucose was measured
every 4 weeks.
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Induction of diabetes
Animals were fasted for 14 h before streptozotocin
(STZ, Sigma Chemical Co, USA, cat# S0130) injection.
STZ was dissolved in10 mM citrate buffer (pH 4.4) and
intraperitoneally injected within 5 min at 65 mg/kg body
weight. Age-matched control rats received equal vol-
umes of vehicle (citrate buffer). Seven days later, blood
was obtained from the tail veins for glucose analysis
using a standard glucometer (One Touch Profile, Life-
scan, Inc., USA). Rats with blood glucose levels higher
than 16.7 mmol/L were considered to be diabetic and
used for the subsequent experiments.
Treatment schedule
After 20 weeks of diabetes induction, the diabetic rats
were divided into two groups according to the glucose
concentration and the body weight: diabetic (n = 17),
XST (n = 8). Then the treatment with XST by intragas-
tric gavage was started. The daily dose of XST given was
1.05 g/kg body weight, which was equivalent to approxi-
mately 7 times the amount of the dose that patients re-
ceive per day. The rats in normal group (n = 11) and
diabetic group were fed with water at the same time.
Color Doppler imaging and trypsin digest preparation
were conducted after 12 weeks of XST treatment. Then
the rats were sacrificed.
Observation by Color Doppler imaging
Color Doppler imaging was used to monitor the flow
velocities before the rats were killed. The blood veloci-
ties of the central retinal artery (CRA) were detected by
Color Doppler (Vevo 2100, VisualSonics, Canada). The
probe was placed on the opened eye following the appli-
cation of sterile contact gel to minimize the force of the
probe on the globe. Peak systolic velocity(PSV), end-
diastolic velocity(EDV), mean velocity(MV), resistance
index(RI) and pulsatility index(PI) of the CRA were
measured.
Immunohistochemical staining
The paraffined slices were deparaffinized and dehy-
drated. For immunohistochemistry, after the endogenous
peroxidases were removed using 0.3% hydrogen peroxid-
ase, the primary antibody against P-MST or P-YAP anti-
body was added to the slices and incubated at 4 °C
overnight. After three washes, the sample slices were in-
cubated with the horseradish peroxidase-conjugated sec-
ondary antibodies; 3, 3′-diaminobenzidine (DAB) was
used as the chromogen. In the end, the hematoxylin
staining was performed.
Trypsin digest method
The retina was isolated and incubated at 37 °C in diges-
tion buffer (0.1 mol/L Tris buffer, pH 7.8), containing 3%
trypsin (Amresco, USA). After 2–3 h of incubation,
when the internal limiting membrane began to separate
from the retina, the retina was transferred to phosphate-
buffered saline (pH 7.4) at room temperature. The vas-
cular tree was washed in distilled water to be freed of
any remaining neural tissue. The preparations were set
on glass slides, air dried, and stained with hematoxylin
and Periodic Acid-Schiff stain (PAS) to evaluate micro-
vascular lesions. The acellular capillaries of the retina
were analyzed. The number of endothelial cells and peri-
cytes were counted, and the ratio was calculated. The
endothelial cells were identified as elliptical and oriented
along the circumference of the capillary, and the peri-
cytes were defined as round in shape and abutting the
outer portion of the capillary wall.
Quantitative real-time PCR
Total RNA was extracted from frozen retina tissues.
RNA concentration was determined by spectrophotom-
eter (Nanodrop 2000, Thermo, USA). Complementary
DNA was synthesized using a reverse transcription re-
agent kit (Roche, USA). Primers were ordered from
Shanghai Shenggong Co Ltd. Amplification and quanti-
tation were performed by real-time PCR (ABI7500,
USA), and β-actin served as the control. The primers for
VEGF and β-actin were as followed: VEGF primer (for-
ward 5′-3′): CAGAAGGGGAGCAGAAAGCC, reverse
(5′-3′): AATGTTCAGCCCCAACCAAGA; β-actin pri-
mer (forward 5′-3′): GCAGGAGTACGATGAGTCCG,
reverse (5′-3′): ACGCAGCTCAGTAACAGTCC.
Western blot analyses
Retinas were homogenized in RIPA buffer (Pulilai, China)
containing protease inhibitors. The lysate was centrifuged,
and the supernatant was collected. Protein content was
assayed using the BCA protein assay (Thermo, USA). The
tissue lysate, which contained 60 μg of protein, was sepa-
rated on 12% SDS-polyacrylamide gels and was trans-
ferred onto polyvinylidene fluoride membranes. The
membranes were blocked for 1.5 h at room temperature
in 5% nonfat dried milk with TBST (Pulilai, China) and
then incubated with a primary antibody overnight at 4 °C.
The membranes were washed and incubated with a sec-
ondary antibody at a dilution of 1:5000 for 1 h. Finally, the
membranes were washed in triplicate with TBST and de-
veloped using enhanced chemiluminescence (GE, USA).
The bands on the film were measured, and density mea-
surements were normalized to β-actin readings.
Statistical analysis
The Shapiro-Wilk test was applied to verify the normal-
ity of the distributions. A two-way analysis of variance
(ANOVA) was used to verify the differences between the
normal distributions, and the Kruskal-Wallis test was
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used to assess differences between nonparametric distri-
butions. For normal distributions, the results were
expressed as the means ± S.D., and the differences were
considered significant when the probability of a Type I
error was lower than 5% (p < 0.05).
Results
Blood glucose and body weight
Blood glucose and body weight were measured every 4
weeks throughout the 32-week period. Diabetic rats
maintained a higher blood glucose (19.1 mmol/
L ~ 26.2 mmol/L), a 4–8-fold increase compared with
the age-matched control rats (vehicle treated; P < 0.001),
and lower body weight (P < 0.001) throughout the ex-
periment period. In contrast to the diabetic group, XST
had no effect on blood glucose and body weight in the
controls (Fig. 1c, d; P > 0.05). No side- effects of XST
were observed.
Blood flow in the CRA
Color Doppler imaging is a noninvasive, reproducible,
and easily applied technique, and it has been shown to
be useful in evaluating hemodynamic changes in several
orbital and retinal vascular diseases [18]. It has been re-
ported that blood flow velocity in the CRA was de-




Fig. 1 The blood glucose and body weight of rats. Diabetic rats were induced by streptozocin. The normal control rats received citrate buffer.
The blood glucose and body weight were measured every 4 weeks. 20 weeks later, the rats whose blood glucose was higher than 16.7 mmol/L
were divided into diabetic group and XST group. Then XST administration started and continued for 12 weeks. a Time schedule. b–c The blood
glucose and body weight before XST administration. ##: P < 0.01, compared to Normal. d–e The blood glucose and body weight after XST
administration. There was no significant difference between diabetic group and XST group. **: P < 0.01, compared to Diabetic
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experiment, blood flow in the CRA was evaluated, and
similar results were observed (Fig. 2). Diabetic rats ex-
hibited a significant reduction in blood flow and an in-
crease in PI and RI in the CRA compared with the
control rats (P < 0.05). PSV, EDV and MV were mark-
edly increased in the XST group compared with the dia-
betic group (P < 0.05, Fig. 2a). XST reduced the RI and
PI remarkably (P < 0.05, Fig. 2b).
Retinal vascular histopathology
Previous studies in animal models have indicated that
the ratio of endothelial cells to pericytes increased sig-
nificantly [19]. When the XST administration ended, the
retinas were removed for trypsin digestion. The results
showed that acellular capillaries and the ratio of endo-
thelial cells to pericytes in diabetic rat retinas increased
compared with normal control rats (P < 0.001, Fig. 3).
Additionally, XST reduced acellular capillaries and the
ratio of endothelial cells to pericytes (P < 0.001, Fig. 3).
These findings suggest that a microvasculature lesion
developed in the diabetic rat retinas and that XST inhib-
ited the pathological changes in diabetic retinopathy.
Hippo pathway changes
The protein levels of the core members of the Hippo path-
way were determined by western blot and immunohisto-
chemistry. The western blot results showed that the Lats
protein level was increased in the retinas of diabetic rats
compared with those of normal rats (P < 0.01, Fig. 4). Dia-
betic rats also exhibited induced TAZ protein expression
(P < 0.01, Fig. 4) accompanied by an increase in TEAD
protein levels (P < 0.01, Fig. 4).
As expected, the XST group had markedly lower levels
of Lats and TAZ compared with the diabetic rats
(P < 0.001 or P < 0.05, Fig. 4). Additionally, rat retinas
displayed a measureable increase in the TEAD levels in
response to XST administration (P < 0.01, Fig. 4).
Immunohistochemistry was performed to evaluate the
distribution and expression levels of P-MST and P-YAP
in rat retinas. As shown in Fig. 4, P-MST was mainly ob-
served in the inner plexiform layer (IPL), and a small
amount was expressed in the ONL and PL. P-YAP was
clearly seen in the photoreceptor layer. In the diabetic
group, P-MST and P-YAP displayed a significant de-
crease in the retinas compared with the normal group
(P < 0.01 or P < 0.001, Fig. 4); however, rats treated with
XST presented a higher expression of P-MST and P-YAP
in their retinas (P < 0.01 or P < 0.001, Fig. 4).
VEGF levels in retina
Previous evidence has shown that VEGF is one of the
most important mediators for DR; therefore, the
VEGF gene and protein levels were examined in the
present study. PCR and western blot analysis showed
that the VEGF gene and protein levels increased
significantly in the retinas of the diabetic group com-
pared with those of the normal control group
(P < 0.01, Fig. 5). Treatment with XST decreased
VEGF gene and protein expression (P < 0.01, Fig. 5).
P-ERK1/2 levels in retina
P-ERK1/2 and ERK1/2 protein expression analysis was
performed using western blot, and the ratio of P-
ERK/ERK was calculated. Increased P-ERK1/2 was ob-
served in the diabetic group compared to the normal
group (P < 0.01, Fig. 6). Compared with diabetic
group, the level of P-ERK1/2 in the retinas of rats
was elevated in XST group (P > 0.05, Fig. 6).
A B
Fig. 2 The effect of XST on blood flow in CRA of rats. At the end of the treatment, rats were anesthetized and blood flow in CRA was measured by color
doppler imaging. XST had a remarkable increase in PSV, EDV and MV and lower levels of PI and RI. Data were represented as mean ± S.D. (n = 6–10). *:
P < 0.05, **: P < 0.01, compared to Diabetic. CRA, central retinal artery; PSV, peak systolic velocity; EDV, end-diastolic velocity; MV, mean velocity; RI, resistance
index; PI, pulsatility index. (a) PSV, EDV and MV of CRA. (b) RI and PI of CRA
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Discussion
In this study, the results showed that the Hippo pathway
became dysregulated in the retinas of diabetic rats, and
XST restored the protein levels of this signaling path-
way. Therefore, we describe here a novel molecular
mechanism by which the Hippo pathway may be in-
volved and play an important role in DR. Additionally
the Hippo pathway has been implicated in underlying
the curative effect of XST.
Previous results indicated that the Hippo pathway me-
diates angiogenesis, which is related to the damages
within the retina in DR. In addition, VEGF has been im-
plicated as one of the most important cytokines with
angiogenic and mitogenic actions, which has great ef-
fects on DR. It has been confirmed that the overexpres-
sion of TEAD increased VEGF promoter activity and
VEGF expression in endothelial cells [20]. Additionally,
silencing YAP inhibited the expression of VEGF [21].
Taken together, these reports suggest that the Hippo
pathway is involved in cell proliferation and angiogenesis
by regulating VEGF. Although not all of the participants
in the crosstalk between the Hippo pathway and VEGF
are fully understood, ERK may function as an intermedi-
ary. YAP, the reporter of the Hippo pathway, is able to
induce ERK phosphorylation [22], and the ERK pathway




Fig. 3 The effect of XST on morphology of rat retinas. The retinas were fixed in formalin for trypsin digestion. a–c The vasculature in midretina. Scale
bar: 50 μm. The images showed the acellular capillaries (black arrow), endothelial cells (green arrows) and pericytes(red arrow). d The acellular capillaries
were counted and expressed as the total number/mm of retina area. There was a remarkable decrease in cellular capillaries in XST group. e The
endothelial cells and pericytes were identified and counted. Then the ratio of endothelial cells number /pericytes number was calculated. XST
administration improved the ratio of endothelial cells number /pericytes number. Data were represented as mean ± S.D. (n = 3–5).*: P < 0.05, **:
P < 0.01, ***: P < 0.001, compared to Diabetic
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and promote VEGF expression [24]. Previous reports
have suggested that the Hippo pathway activates ERK,
which modulates VEGF and facilitates angiogenesis.
Our findings that MST, Lats, YAP, TAZ and TEAD
were all altered in the retinas of rats with DR led us to
conclude that the Hippo pathway may be the underlying
factor in the process of DR. Additionally, VEGF and
P-ERK were elevated in diabetic rats, which implies that






Fig. 4 The effect of XST on protein levels of Hippo pathway. a–d the protein levels of Lats, TAZ and TEAD were evaluated by WB. XST decreased
levels of Lats, TAZ and TEAD protein. e–g Distribution and expression of P-MST and P-YAP were measured using IHC. P-MST was mainly observed
in inner plexiform layer and small amount was expressed in outer nuclear layer and photoreceptor layer. P-YAP was clearly seen photoreceptor
layer. An elevation of P-MST and P-YAP were observed in XST group. Data were represented as mean ± S.D. (n = 3–4).*: P < 0.05, **: P < 0.01, ***:
P < 0.001, compared to Diabetic
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Although the way that the Hippo pathway partici-
pates in DR has not been examined, several upstream
regulators of the Hippo pathway, such as GPCR,
SCRIB and cadherin [5], are suspected to regulate
vascular cell proliferation, migration [25, 26] or insu-
lin secretion [27]. Thus, Hippo pathway activity is
tightly coupled to angiogenesis and glucose metabol-
ism. Angiogenesis and hyperglycemia are fundamental
features of DR and might thus underlie the deregu-
lated Hippo pathway activity in DR.
In the current study, XST affected the protein levels
of MST, Lats, YAP, TAZ and TEAD. These results
suggest that the Hippo pathway could be a thera-
peutic target for DR. XST is composed of many
major active constituents, including tanshinone, sapo-
nins, harpagoside, astragaloside and flavonoids.
Tanshinone-IIA and cryptotanshinone [28], Ginseno-
side Rd. [29], notoginsenoside R1 [30], Aucubin [31]
are responsible for the regulation of VEGF or P-ERK.
The VEGF, P-ERK and Hippo signaling pathways
could interact and contribute to the pathological
process, so it has been proposed that some of the ac-
tive constituents isolated from XST can collaborate to
control retinal endothelial cell proliferation or migra-
tion and inhibit angiogenesis.
Conclusions
In conclusion (Fig. 7), this study documents an im-
portant role for the Hippo pathway in the process of
DR and offers a potential drug target for the manage-
ment of DR. However in later experiments, maybe it
is necessary to confirm the importance of Hippo
pathway to DR by knockdown technology. Further-
more, this study demonstrates that XST exhibits
Fig. 7 the Hippo pathway is involved in diabetic retinopathy, which
is inhibited by Fufang Xueshuantong
A B
Fig. 6 The effect of XST on protein levels P-ERK and ERK. a The ratio of
P-ERK/ERK was compared. b The images of WB results. XST decreased
the ratio of P-ERK/ERK. Data were represented as mean ± S.D. (n = 3–4).
**: P < 0.01, compared to Diabetic
Fig. 5 The effect of XST on gene and expression levels of VEGF. a The gene level of VEGF was determined by PCR. XST lead to a reduction of
VEGF gene level. b–c The protein level of VEGF was evaluated by WB. XST displayed a decrease of VEGF protein level. Data were represented as
mean ± S.D. (n = 3–4).*: P < 0.05, **: P < 0.01, compared to Diabetic
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effects on the Hippo pathway in rats with DR and
provides molecular mechanisms underlying the use of
XST for the treatment of DR.
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